Home

Case Study

Increasing Therapy Starts Through AI-Powered Precise Patient Identification

Increasing Therapy Starts Through AI-Powered Precise Patient Identification

IQVIA
Pages 1 Pages

Describes how AI/ML helped a client with an aggressive lymphoma drug identify patients unresponsive to first-line therapy. By analyzing claims data and HCP characteristics, IQVIA triggered alerts to physicians treating likely candidates, leading to a 27% increase in therapy starts within five months. This approach optimized commercialization resources, improved patient outcomes, and demonstrated how predictive modeling can accelerate adoption of second-line therapies.

Join for free to read

You Might Also Like


AI-Powered Personalization: From B2C Sales to B2B Distributors
White Paper AI-Powered Personalization: From B2C Sales to B2B Distributors
proton.ai

AI-Powered Talent Acquisition and Mobility: Speed to Iconic Outcomes
Ebook AI-Powered Talent Acquisition and Mobility: Speed to Iconic…
Workday

AI-Powered Opportunities for Marketers
Ebook AI-Powered Opportunities for Marketers
Salesforce

AI-powered healthcare: Shaping the future of population health
Ebook AI-powered healthcare: Shaping the future of population health
PwC Network

More from IQVIA


Optimizing Patient Profiling, Market Sizing, and Physician Targeting at Pre-launch with a Comprehensive AI-Powered Solution
Case Study Optimizing Patient Profiling, Market Sizing, and Physician…
IQVIA

Adapting to New Treatment Paradigm Shifts Through Therapy Awareness
Case Study Adapting to New Treatment Paradigm Shifts Through Therapy…
IQVIA

Leveraging Predictive Models for Ultra-Rare Disorder Identification
Case Study Leveraging Predictive Models for Ultra-Rare Disorder…
IQVIA

IRT and eClinical Technology Considerations for Cell and Gene Therapy
Case Study IRT and eClinical Technology Considerations for Cell and Gene…
IQVIA
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info